Editorial · 2026 · Open access
Beyond the label: patient-reported outcomes and post-approval communication in oncology
BMJ Oncology, 5(1), e001082 · Published 1 January 2026 · DOI 10.1136/bmjonc-2026-001082
In brief
“Beyond the label: patient-reported outcomes and post-approval communication in oncology” is an 2026 editorial by Jens Lehmann, published in BMJ Oncology. OpenAlex counts 1 citations as of 22 November 2026. It is open access under a CC BY-NC licence: the full text is free to read at BMJ Oncology.
- Citations
- 1
- Most cited in
- 2026 (1)
- References
- 5
- Authors
- 1
Abstract
Cancer clinical trials form the foundation for the approval and use of new anticancer therapies. Alongside traditional endpoints such as survival and tumour response, patient-reported outcomes (PROs) are now a cornerstone of oncology trials and are increasingly expected by regulators.1 By capturing symptoms and functional health directly from patients, PROs provide essential information for patient-focused drug development and shared decision-making.
Cite this paper
Formatted from the catalogue record. Check names, capitals and page numbers against the paper before you submit.
APA 7
Lehmann, J. (2026). Beyond the label: patient-reported outcomes and post-approval communication in oncology. BMJ Oncology, 5(1), e001082. https://doi.org/10.1136/bmjonc-2026-001082
MLA 9
Lehmann, Jens. “Beyond the label: patient-reported outcomes and post-approval communication in oncology.” BMJ Oncology, vol. 5, no. 1, 2026, p. e001082. https://doi.org/10.1136/bmjonc-2026-001082.
Chicago
Lehmann, Jens. 2026. “Beyond the label: patient-reported outcomes and post-approval communication in oncology.” BMJ Oncology 5 (1): e001082. https://doi.org/10.1136/bmjonc-2026-001082.
Harvard
Lehmann, J. (2026) ‘Beyond the label: patient-reported outcomes and post-approval communication in oncology’, BMJ Oncology, 5(1), p. e001082. doi:10.1136/bmjonc-2026-001082.
IEEE
J. Lehmann, “Beyond the label: patient-reported outcomes and post-approval communication in oncology,” BMJ Oncology, vol. 5, no. 1, p. e001082, 2026, doi: 10.1136/bmjonc-2026-001082.
BibTeX
@article{lehmann2026beyond,
title = {{Beyond the label: patient-reported outcomes and post-approval communication in oncology}},
author = {Lehmann, Jens},
journal = {BMJ Oncology},
year = {2026},
volume = {5},
number = {1},
pages = {e001082},
doi = {10.1136/bmjonc-2026-001082},
url = {https://doi.org/10.1136/bmjonc-2026-001082}
}
Download for a reference manager: BibTeX (.bib) · RIS for Zotero, Mendeley and EndNote (.ris)
Topic and keywords
Health Sciences › Medicine › Oncology › Cancer survivorship and care
- patient-reported outcomes
- cancer clinical trials
- cancer therapy
- regulatory expectations
- patient-focused drug development
- shared decision-making
- cancer symptoms
- functional health
Work with this paper
Most-cited papers in Medicine
- Yaşlı Kadınlarda Üreme SağlığıDemet Kokanalı, Yaprak Engin Üstün · Jinekoloji-Obstetrik ve Neonatoloji Tıp Dergisi · 2019 · 169,630 citations
- Global Cancer Statistics 2020: GLOBOCAN Estimates of Incidence and Mortality Worldwide for 36 Cancers in 185 CountriesHyuna Sung, Adalberto M. Filho, Mathieu Laversanne and 5 more · CA A Cancer Journal for Clinicians · 2021 · 119,885 citations
- “Mini-mental state”Marshal F. Folstein, Susan E. Folstein, Paul R. McHugh · Journal of Psychiatric Research · 1975 · 90,424 citations
- Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countriesFreddie Bray, Jacques Ferlay, Isabelle Soerjomataram and 3 more · CA A Cancer Journal for Clinicians · 2018 · 87,396 citations
- Hallmarks of Cancer: The Next GenerationDouglas Hanahan, Robert A. Weinberg · Cell · 2011 · 69,758 citations
Questions about this paper
How do I cite this paper in APA style?
Lehmann, J. (2026). Beyond the label: patient-reported outcomes and post-approval communication in oncology. BMJ Oncology, 5(1), e001082. https://doi.org/10.1136/bmjonc-2026-001082
How many times has this paper been cited?
1 times, according to OpenAlex on 22 November 2026. Google Scholar and Scopus count different sets of sources, so their numbers differ.
Is this paper free to read?
Yes. It is open access at BMJ Oncology: sign in and open the PDF from this page.
Who wrote this paper?
Jens Lehmann.
What is the DOI of this paper?
10.1136/bmjonc-2026-001082, permanently at https://doi.org/10.1136/bmjonc-2026-001082. Sign in and open it from this page.
Bibliographic data from OpenAlex (CC0), last checked 22 November 2026. ResearchGuru does not host this paper; once you are signed in, the links open it at the publisher or the repository that does.